ACS - Molecular Pharmaceutics

The latest news from ACS - Molecular Pharmaceutics
Noninternalizing Targeted Cytotoxics for Cancer Therapy
ACS - Molecular Pharmaceutics, March 18, 2015
Molecular PharmaceuticsDOI: 10.1021/mp500798y
Sensitive ELISA Method for the Measurement of Catabolites of Antibody-Drug Conjugates (ADCs) in Target Cancer Cells
ACS - Molecular Pharmaceutics, March 17, 2015
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.5b00028
Mechanism for Enhanced Absorption of a Solid Dispersion Formulation of LY2300559 Using the Artificial Stomach Duodenum Model
ACS - Molecular Pharmaceutics, March 17, 2015
Molecular PharmaceuticsDOI: 10.1021/mp5006036
Redox-Responsive Polymer-Drug Conjugates Based on Doxorubicin and Chitosan Oligosaccharide-g-stearic Acid for Cancer Therapy
ACS - Molecular Pharmaceutics, March 16, 2015
Molecular PharmaceuticsDOI: 10.1021/mp500710x
In Silico Identification of PAP-1 Binding Sites in the Kv1.2 Potassium Channel
ACS - Molecular Pharmaceutics, March 16, 2015
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.5b00023
Pharmacologic Sensitivity of Paclitaxel to Its Delivery Vehicles Drives Distinct Clinical Outcomes of Paclitaxel Formulations
ACS - Molecular Pharmaceutics, March 16, 2015
Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.5b00026
Maytansinoid-BODIPY Conjugates: Application to Microscale Determination of Drug Extinction Coefficients and for Quantification of Maytansinoid Analytes
ACS - Molecular Pharmaceutics, March 16, 2015
Molecular PharmaceuticsDOI: 10.1021/mp500843r
Synthesis and in Vitro and in Vivo Evaluation of an 18F-Labeled Neuropeptide Y Analogue for Imaging of Breast Cancer by PET
ACS - Molecular Pharmaceutics, March 13, 2015
Molecular PharmaceuticsDOI: 10.1021/mp500601z
Inhibition of Cancer Cell Proliferation and Breast Tumor Targeting of pHLIP-Monomethyl Auristatin E Conjugates
ACS - Molecular Pharmaceutics, March 13, 2015
Molecular PharmaceuticsDOI: 10.1021/mp500779k
Preclinical Dose Number and Its Application in Understanding Drug Absorption Risk and Formulation Design for Preclinical Species
ACS - Molecular Pharmaceutics, March 11, 2015
Molecular PharmaceuticsDOI: 10.1021/mp500504q
Stories 11 - 20 of 414